Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenta Okada

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Acta Diabetologica|April 30, 2011
The correlation of common carotid arterial diameter with atherosclerosis and diabetic retinopathy in patients with type 2 diabetes mellitusMichiaki Miyamoto, Kazuhiko Kotani, Kenta Okada, et al.
Hospital Practice (1995)|November 8, 2011
Urinary protein as a marker for systolic blood pressure reduction in patients with type 2 diabetes mellitus participating in an in-hospital diabetes education programKenta Okada, Michiaki Miyamoto, Kazuhiko Kotani, et al.
Endocrine Journal|August 25, 2010
Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitusKenta Okada, Hiroaki Yagyu, Kazuhiko Kotani, et al.
Endocrine Journal|August 2, 2012
Ezetimibe, an inhibitor of Niemann-Pick C1-like 1 protein, decreases cholesteryl ester transfer protein in type 2 diabetes mellitusHiroaki Yagyu, Shuichi Nagashima, Manabu Takahashi, et al.
Tobacco Induced Diseases|August 14, 2012
Current smoking status may be associated with overt albuminuria in female patients with type 1 diabetes mellitus: a cross-sectional studyKenta Okada, Jun-Ichi Osuga, Kazuhiko Kotani, et al.
Biochemical and Biophysical Research Communications|May 7, 2003
Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-gammaHaruaki Kageyama, Tsutomu Hirano, Kenta Okada, et al.
Endocrinology, Diabetes & Metabolism Case Reports|April 29, 2021
A novel SOX10 nonsense mutation in a patient with Kallmann syndrome and Waardenburg syndromeTetsuji Wakabayashi, Akihito Takei, Nobukazu Okada, et al.
Journal of Atherosclerosis and Thrombosis|May 8, 2013
Arterial wall elasticity measured using the phased tracking method and atherosclerotic risk factors in patients with type 2 diabetesMichiaki Miyamoto, Kazuhiko Kotani, Kenta Okada, et al.
Kidney International|May 20, 2003
Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: comparison with apoprotein CIIITsutomu Hirano, Taro Sakaue, Asako Misaki, et al.
Diabetes Research and Clinical Practice|December 14, 2011
Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitusHiroaki Yagyu, Kenta Okada, Shin Sato, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Acta Diabetologica|April 30, 2011
The correlation of common carotid arterial diameter with atherosclerosis and diabetic retinopathy in patients with type 2 diabetes mellitusMichiaki Miyamoto, Kazuhiko Kotani, Kenta Okada, et al.
Hospital Practice (1995)|November 8, 2011
Urinary protein as a marker for systolic blood pressure reduction in patients with type 2 diabetes mellitus participating in an in-hospital diabetes education programKenta Okada, Michiaki Miyamoto, Kazuhiko Kotani, et al.
Endocrine Journal|August 25, 2010
Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitusKenta Okada, Hiroaki Yagyu, Kazuhiko Kotani, et al.
Endocrine Journal|August 2, 2012
Ezetimibe, an inhibitor of Niemann-Pick C1-like 1 protein, decreases cholesteryl ester transfer protein in type 2 diabetes mellitusHiroaki Yagyu, Shuichi Nagashima, Manabu Takahashi, et al.
Tobacco Induced Diseases|August 14, 2012
Current smoking status may be associated with overt albuminuria in female patients with type 1 diabetes mellitus: a cross-sectional studyKenta Okada, Jun-Ichi Osuga, Kazuhiko Kotani, et al.
Biochemical and Biophysical Research Communications|May 7, 2003
Lipoprotein lipase mRNA in white adipose tissue but not in skeletal muscle is increased by pioglitazone through PPAR-gammaHaruaki Kageyama, Tsutomu Hirano, Kenta Okada, et al.
Endocrinology, Diabetes & Metabolism Case Reports|April 29, 2021
A novel SOX10 nonsense mutation in a patient with Kallmann syndrome and Waardenburg syndromeTetsuji Wakabayashi, Akihito Takei, Nobukazu Okada, et al.
Journal of Atherosclerosis and Thrombosis|May 8, 2013
Arterial wall elasticity measured using the phased tracking method and atherosclerotic risk factors in patients with type 2 diabetesMichiaki Miyamoto, Kazuhiko Kotani, Kenta Okada, et al.
Kidney International|May 20, 2003
Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: comparison with apoprotein CIIITsutomu Hirano, Taro Sakaue, Asako Misaki, et al.
Diabetes Research and Clinical Practice|December 14, 2011
Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitusHiroaki Yagyu, Kenta Okada, Shin Sato, et al.
Pageof 5